WAVE Life Sciences Ltd
NASDAQ:WVE

Watchlist Manager
WAVE Life Sciences Ltd Logo
WAVE Life Sciences Ltd
NASDAQ:WVE
Watchlist
Price: 6.64 USD -12.29%
Market Cap: 1B USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
N/A
Revenue
Forecast
N/A
Operating Income
Forecast
N/A
Net Income
Forecast
N/A

Wall Street
Price Targets

WVE Price Targets Summary
WAVE Life Sciences Ltd

Wall Street analysts forecast WVE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for WVE is 23.97 USD with a low forecast of 14.14 USD and a high forecast of 37.8 USD.

WVE Lowest Forecast
Wall Street Target
14.14 USD
113% Upside
WVE Average Forecast
Wall Street Target
23.97 USD
261% Upside
WVE Highest Forecast
Wall Street Target
37.8 USD
469% Upside
Lowest
Price Target
14.14 USD
113% Upside
Average
Price Target
23.97 USD
261% Upside
Highest
Price Target
37.8 USD
469% Upside
WAVE Life Sciences Ltd Competitors:
Price Targets
B
053030
Binex Co Ltd
144% Upside
4569
Kyorin Holdings Inc
7% Upside
H
600566
Hubei Jumpcan Pharmaceutical Co Ltd
92% Upside
SUPN
Supernus Pharmaceuticals Inc
20% Upside
B
053030
Binex Co Ltd
144% Upside
4569
Kyorin Holdings Inc
7% Upside
H
600566
Hubei Jumpcan Pharmaceutical Co Ltd
92% Upside
SUPN
Supernus Pharmaceuticals Inc
20% Upside
DERM
Journey Medical Corp
53% Upside

Revenue
Forecast

Revenue Estimate
WAVE Life Sciences Ltd

For the last 8 years the compound annual growth rate for WAVE Life Sciences Ltd's revenue is 78%. The projected CAGR for the next 3 years is 13%.

78%
Past Growth
13%
Estimated Growth
Estimates Accuracy
-3%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
WAVE Life Sciences Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
WAVE Life Sciences Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-75%
Average Miss
What are analyst estimates?

See Also

Summary
WVE intrinsic value, competitors valuation, and company profile.
DCF Valuation
WVE stock valuation using Discount Cash Flow valuation method.
Relative Valuation
WVE stock valuation using valuation multiples.
Wall Street Estimates
WVE price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
WVE stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is WVE's stock price target?
Price Target
23.97 USD

According to Wall Street analysts, the average 1-year price target for WVE is 23.97 USD with a low forecast of 14.14 USD and a high forecast of 37.8 USD.

What is WAVE Life Sciences Ltd's Revenue forecast?
Projected CAGR
13%

For the last 8 years the compound annual growth rate for WAVE Life Sciences Ltd's revenue is 78%. The projected CAGR for the next 3 years is 13%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 243,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.